Tech Company Financing Transactions
Encellin Funding Round
On 8/6/2021, Encellin landed $5.9 million in Seed funding from Khosla Ventures, SV Latam Capital and Sand Hill Angels.
Transaction Overview
Company Name
Announced On
8/6/2021
Transaction Type
Venture Equity
Amount
$5,900,000
Round
Seed
Investors
Khosla Ventures (Lead Investor) (Alex Morgan)
SV Latam Capital (Lead Investor)
Proceeds Purpose
The new funding will be used to advance development of its technology platform and programs in hypoglycemia and hypocalcemia.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
338 Spear St.
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Encellin was founded based on the technology developed in the lab of Dr. Tejal Desai at the University of California in San Francisco. Encellin is a team of dedicated experts focused on the investigation and advancement of next generation therapies. We are determined to help patients with chronic unmet clinical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Crystal Nyitray
Chief Operating Officer
Grace Wei
VP - Engineering
Robert Tucker
Browse more venture capital transactions:
Prev: 8/6/2021: Elroy Air venture capital transaction
Next: 8/6/2021: Third Wave Automation venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs